AlphAIAlphAI — Financial news for AI agents
investing.comOCT 221 min read$LAZ

Lazard earnings missed by $0.08, revenue fell short of estimates

Lazard (LAZ) reported Q3 EPS of $0.36, missing estimates by $0.08, with revenue at $814M, below consensus of $848.6M. The stock is down 15.74% in 3 months and 23.92% in 12 months, with 8 negative EPS revisions in 90 days. InvestingPro rates its financial health as 'good performance'.

Original reporting
investing.com
Published Oct 22, 2026, 10:35 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 10:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$LAZ
Bearish
high confidence
Mentioned
$LAZ
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$LAZBearishMed
01

Why it matters

The earnings shortfall may prompt analysts to downgrade forecasts and trigger a sell‑off in the stock.

02

Market read

Earnings miss is a material event for LAZ and may influence sentiment toward the broader financial advisory sector.

03

What to watch

Recent cost‑cutting initiatives and a strong balance sheet may cushion longer‑term outlook.

Relevance 8/10Novelty 8/10Timing: today

Background

Lazard is a global financial advisory and asset management firm; its earnings are closely watched for insight into deal flow.

Company-level read

Ticker impact

$LAZBearishHigh confidence
Context

Lazard reported Q3 EPS of $0.36, missing estimates by $0.08 and revenue of $814M below $848.6M consensus.

Expected impact

downward pressure as investors price in the earnings shortfall

Evidence & confidence

The miss on both EPS and revenue is a fresh primary disclosure likely to trigger sell‑offs.

Market effects

Sector

Potential drag on financial services sector as peers may be re‑rated.

Regional

US market may see modest bearish bias in banking/finance stocks.

Global

Limited to investors tracking US investment banks and advisory firms.

Counterpoint

What could challenge this read

The miss could be a short‑term overreaction; underlying advisory franchise remains strong.

Key entities

  • Company
    Lazard Ltd.

    Global financial advisory and asset management firm.

Read at source← All news

StoryLazard posts Q3 2026 revenue growth but earnings miss and announces Campbell Lutyens acquisition

Also covered by

5 outlets

Related articles

OCT 23
$LAZMed

Citizens reiterates Lazard stock rating citing strong forward indicators

Citizens maintained its Market Outperform rating and $60.00 price target on Lazard (NYSE:LAZ) after its Q3 2026 results. Lazard reported adjusted EPS of $0.36, below estimates, and revenue of $805M, up 11% YoY but below expectations. Shares have fallen 21% YTD. Goldman Sachs raised its price target to $35 but kept a Sell rating, citing expense management. Lazard's dividend yield is 5.36%.

investing.com2 min
OCT 22
$LAZMed

Lazard Inc (LAZ) (Q3 2026) Earnings Call Highlights: Record Advisory Revenue

Lazard Inc (LAZ) reported Q3 2026 earnings with record advisory revenue but faced asset management outflows of $2.3B. CEO Peter Orszag highlighted growth opportunities from the Campbell Lutzens acquisition and strong advisory pipeline. CFO Tracy Farr discussed compensation ratio management. Management acknowledged macroeconomic challenges and potential M&A delays due to higher interest rates.

finance.yahoo.com2 min
OCT 22
$LAZLow

Goldman Sachs raises Lazard stock price target on expense management

Goldman Sachs raised its price target for Lazard (NYSE:LAZ) to $35 from $32, maintaining a Sell rating. Lazard's Q3 2026 adjusted EPS of $0.36 missed estimates, with revenue 6% below expectations. Despite this, the company expects strong Financial Advisory performance and positive net organic flows in asset management. Goldman reduced its earnings estimates for 2026-2028 but increased its target P/E multiple.

investing.com2 min
OCT 22
$LAZMed

What Lazard (LAZ) Said on Its Q3 Earnings Call

Lazard (LAZ) reported strong Q3 results, with advisory revenue split 61% M&A and 39% non-M&A. Conflict clearances rose 30%+ YoY, and its 2027 pipeline is twice 2026's. Asset management fees hit a record $321M, up 18% YoY, with AUM at $284B. Management expects H2 2026 to outperform H1, driven by strategic transactions and restructuring activity. The company returned $88M to shareholders and plans efficiency initiatives.

finance.yahoo.com3 min
OCT 22
$LAZHighAI 8/10

Lazard (LAZ) Q3 2026 Earnings Call Transcript

Lazard (LAZ) reported Q3 2026 earnings, highlighting 11% year-over-year revenue growth. The firm plans to close its acquisition of Campbell Lutyens, launching Lazard CL, expected to generate $500M in 2027 revenue. Financial advisory saw record revenue, with strong forward indicators and pipeline growth. Asset management reported record gross inflows of $54B for the first nine months.

finance.yahoo.com3 min
OCT 22
$LAZMed

Why Lazard (LAZ) stock is trading lower today

Lazard (LAZ) shares fell 3% after Q3 earnings missed estimates, with adjusted EPS of $0.36 vs. $0.44 expected and revenue of $814M vs. $848.6M projected. The company reported net income of $29M, or $0.26 per share. The stock was trading at $36.18, down 36.5% from its 52-week high.

financialcontent.com2 min